Status:

COMPLETED

Glycemic and Satiety Response Study of Fibre-Enriched Pudding Products

Lead Sponsor:

University of Guelph

Collaborating Sponsors:

Ontario Ministry of Agriculture, Food and Rural Affairs

Natural Sciences and Engineering Research Council, Canada

Conditions:

Type 2 Diabetes Mellitus

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

The purpose of this study is to determine the specific properties of a variety of dietary fibres that lead to different postprandial glycemic and satiety responses in individuals at risk for type 2 di...

Detailed Description

The purpose of this study is to determine the specific properties of a variety of dietary fibres that lead to different postprandial glycemic and satiety responses in individuals at risk for type 2 di...

Eligibility Criteria

Inclusion

  • Men/Women
  • Age 18-70 years
  • CANRISK Questionnaire score ≥21 (brief questionnaire that identifies risk of diabetes)
  • BMI ≥25 and \<40 kg/m2
  • Prior use of acetaminophen

Exclusion

  • Smokers
  • Food allergies or any life-threatening allergy (food or otherwise)
  • Acetaminophen allergy
  • Gastrointestinal conditions or illnesses (Including, but not limited to, lactose intolerance, Celiac, Crohn's, Ulcerative Colitis (UC), Irritable Bowel Disorder (IBD))
  • Serious major medical condition (i.e. renal, liver)
  • Pregnant or breastfeeding
  • Food Neophobia Scale score between 30 and 54 (Food Neophobia Scale is a questionnaire which is intended to screen out individuals who are unsure of consuming new products)
  • TFEQ-CR \>16 (TFEQ is a questionnaire to screen for restrained eaters)
  • Alcohol consumption\>4 drinks/sitting
  • Medication or natural health products (NHPs) used for diabetes (glycemic control)
  • Medication or NHPs contraindicated with acetaminophen
  • Recent or intended significant weight loss or gain (i.e. \>4 kg in previous 3 months)

Key Trial Info

Start Date :

November 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2015

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT02289612

Start Date

November 1 2014

End Date

October 1 2015

Last Update

May 8 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Human Nutraceutical Research Unit

Guelph, Ontario, Canada, N1G 2W1